Company Monitoring Page for Astellas

latest headlines for company on cafepharma

Astellas has menopause accelerated approval ambition thwarted by FDA at last minute
Fierce Biotech
Mon, 02/20/23 - 12:19 pm
Tags:
Astellas, menopause, fezolinetant, FDA
ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J
Fierce Pharma
Fri, 02/17/23 - 09:36 am
Tags:
ASCO GU, Pfizer, Astellas, Xtandi, prostate cancer
Astellas buys Super Bowl commercial spot to raise menopause awareness
Medical Marketing and Media
Sun, 02/12/23 - 07:36 pm
Tags:
Astellas, menopause, Super Bowl, DTC advertising, television ads, fezolinetant
Astellas Taps New CEO in Nod to Accelerated Growth
BioSpace
Mon, 02/6/23 - 10:56 am
Tags:
Astellas, Pharma CEOs, Naoki Okamura
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Wed, 01/25/23 - 10:44 am
Tags:
Sandoz, Novartis, Astellas, antifungals, Mycamine, generics
Astellas, after years of gene therapy woes, gets rare boost with FDA lifting of Pompe clinical hold
Fierce Biotech
Fri, 01/20/23 - 10:24 am
Tags:
Astellas, Pompe disease, gene therapy, AT845
ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
EP Vantage
Fri, 01/20/23 - 10:19 am
Tags:
ASCO-GI, zolbetuximab, cancer of the gastro-esophageal junction, Astellas
Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
Stat
Wed, 01/11/23 - 10:51 am
Tags:
cancer, oncology, Joe Biden, Astellas, Xtandi, prostate cancer
Astellas loses bid to block Lexiscan generics in US
Pharmaphorum
Wed, 01/4/23 - 05:15 pm
Tags:
legal, Astellas, Pfizer, Lexiscan, patents
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Clinical Trials Arena
Fri, 12/16/22 - 10:21 am
Tags:
Astellas, clinical trials, zolbetuximab, gastric cancer
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Fierce Biotech
Thu, 11/17/22 - 10:37 am
Tags:
Astellas, zolbetuximab, clinical trials, cancer, gastric cancer
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
Endpoints
Wed, 11/2/22 - 11:00 pm
Tags:
Astellas, hot flashes, menopause, fezolinetant, patient education
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma Dive
Tue, 11/1/22 - 07:09 pm
Tags:
gene therapy, M&A, Akouos, AGTC, Taysha Gene Therapies, Astellas, Eli Lilly, Syncona
Astellas Pays $50M for Access to Taysha's Rett, GAN Programs
BioSpace
Wed, 10/26/22 - 10:29 am
Tags:
Taysha Gene Therapies, Astellas, gene therapy, Rett Syndrome, GAN
Astellas takes stake in gene therapy developer Taysha
BioPharma Dive
Mon, 10/24/22 - 11:12 pm
Tags:
Astellas, Taysha Gene Therapies, gene therapy
Astellas, Pantherna add organ to mRNA tie-up; Rocket launches sale of six figures worth of stock
Endpoints
Wed, 10/5/22 - 10:41 am
Tags:
Astellas, Pantherna, MRNA
ESMO: Seagen's Padcev pulls its weight in combo with Merck's Keytruda
Fierce Pharma
Thu, 09/8/22 - 04:40 pm
Tags:
Merck, Keytruda, Astellas, Seagen, Padcev, ESMO, urothelial cancer
Astellas reports Phase III data of fezolinetant for menopause-linked VMS
Clinical Trials Arena
Tue, 09/6/22 - 10:50 am
Tags:
Astellas, clinical trials, menopause, China, fezolinetant, vasomotor symptoms, hot flashes
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
Tags:
artificial intelligence, Pfizer, Novartis, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Takeda, GSK, Bayer, Astellas
Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record
Fierce Biotech
Thu, 08/18/22 - 12:40 pm
Tags:
Astellas, menopause, FDA, clinical trials, Asia, fezolinetant, hot flashes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.